NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Carlyle Group Acquires Majority Stake in Knack RCM and EqualizeRCM

The Carlyle Group Inc. announced on Monday that it has acquired a majority stake in healthcare revenue cycle management firms Knack RCM and EqualizeRCM. The terms of the deal were not disclosed.

Key Players in the Deal The acquisition will see Rajiv Sharma, founder of Knack, and Nagi Rao, co-founder of EqualizeRCM, reinvest some of their proceeds in the newly created RCM platform. This move is expected to help Carlyle expand its reach, strengthen leadership, and accelerate its artificial intelligence capabilities.

Industry Expertise Knack and EqualizeRCM specialize in serving physician groups, durable medical equipment providers, rural hospitals, and other specialty segments. The deal is expected to enable Carlyle to deliver more robust and tailored solutions to its clients by integrating its advisory expertise with the advanced analytics and global operations of Knack and EqualizeRCM.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Strategic Benefits The acquisition will allow Carlyle to tackle complex revenue cycle management tasks, including rural cost reports, durable medical equipment intake, and challenging anesthesia cases. Knack Chief Executive Officer Gautam Barai noted that the agreement will help the companies address these complex issues.

Future Plans Carlyle has expressed its intention to pursue further opportunities in the revenue cycle management industry, building on the strategic benefits of this acquisition.

Investor Takeaway

Investors should consider the potential benefits of Carlyle Group's acquisition of Knack and EqualizeRCM for the healthcare revenue cycle management industry.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.